Granite Point Capital Management, L.P. Athenex, Inc. Transaction History

Granite Point Capital Management, L.P.

4 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2019 Jul 29, 2019	SELL	$9.44 - $19.8 $377,600 - $792,000	-40,000 Closed	0 $0
Q1 2019 May 14, 2019	BUY	$11.11 - $13.49 $444,400 - $539,600	40,000 New	40,000 $490,000
Q2 2018 Aug 13, 2018	SELL	$15.88 - $19.5 $635,200 - $780,000	-40,000 Closed	0 $0
Q1 2018 May 15, 2018	BUY	$13.53 - $17.47 $541,200 - $698,800	40,000 New	40,000 $680,000

1.46M

Ticker ATNX
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—Specialty & Generic
Shares Outstandng 156,790,000
Market Cap $1.57M
Description
Athenex, Inc., a biopharmaceutical company, engages in the discovery, development, and commercialization of drugs for the treatment of cancer. It operates through three segments: Oncology Innovation Platform, Global Supply Chain Platform, and Commercial Platform. The company's Orascovery product candidates include Oral paclitaxel and encequidar,...

Get notified when there are updates to the investment portfolio of Granite Point Capital Management, L.P., based on Form 13F filings with the SEC.

Stay updated on Granite Point Capital Management, L.P. with notifications on news.